REG - Judges ScientificPLC - Appointment of Group Acquisitions Executive

Judges ScientificAnnouncement

Tue 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250701:nRSA0808Pa&default-theme=true

RNS Number : 0808P  Judges Scientific PLC  01 July 2025

1 July 2025

Judges Scientific plc

 

("Judges Scientific", "Judges" or the "Company")

 

Appointment of Group Acquisitions Executive

 

Judges Scientific, the group focused on acquiring and developing companies in
the scientific instrument sector, is pleased to announce the appointment of
Rik Armitage as Group Acquisitions Executive with immediate effect.

 

Rik will support David Cicurel, CEO of Judges, as the Group continues to
execute its strategy, further build its capacity to grow the pipeline of
potential deals and maintain its disciplined acquisition process. He will join
the Group's recently formed Executive Committee.

 

Rik has over thirty years' experience in strategy and M&A in manufacturing
and technology businesses. He was most recently with Oxford Instruments plc
where, since 2020, he was Head of Corporate Development and helped identify
and complete three acquisitions in laboratory instruments and scientific
cameras. Prior to this, Rik spent 14 years with the defence company Chemring
Group plc, where he implemented an acquisition-based growth and
diversification strategy, completing twelve acquisitions in energetic
materials and defence electronics across the UK, Europe and US.

 

David Cicurel, Chief Executive Officer, commented: "We are delighted to
welcome Rik to Judges. He brings with him a vast amount of experience and we
look forward to benefitting from his expertise as the Group continues to
execute its buy and build growth strategy."

 

 

 

For further information please contact:

 

 Judges Scientific plc                                        Shore Capital (Nominated Adviser & Joint Broker)

 David Cicurel, CEO                                           Stephane Auton

 Brad Ormsby, CFO                                             Harry Davies-Ball

 Tel: +44 (0) 20 3829 6970                                    Tel: +44 (0) 20 7408 4090

 Panmure Liberum (Joint Broker)                               Investec Bank plc (Joint Broker)

 Edward Mansfield                                             Virginia Bull

 Nikhil Varghese                                              Carlton Nelson

 Tel : +44 (0) 20 3100 2222                                   Tel: +44 (0) 20 7597 4000

 Alma (Financial Public Relations)

 Sam Modlin

 Rebecca Sanders-Hewett

 Joe Pederzolli

 Sarah Peters

 Tel: +44 (0) 20 3405 0205

 judges@almastrategic.com (mailto:judges@almastrategic.com)

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and
developing companies in the scientific instrument sector.  The Group now
consists of 25 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to
a diverse range of markets including: higher education institutions,
scientific research facilities, manufacturers and regulatory authorities.
The UK is a recognised centre of excellence for scientific instruments.
The Group has received five Queen's Awards for innovation and export.

The Group's companies predominantly operate in global niche markets, with long
term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that
generate sustainable profits and cash.  Shareholder returns are created
through the reduction of debt, organic growth and dividends.

For further information, please visit www.judges.uk.com
(http://www.judges.uk.com/)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCSDEFASEISEFM